Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(8 sites)

Belgium

Ghent University Hospital, Ghent, East Flanders

AZ Sint Blasius Dendermonde, Dendermonde

AZ Alma Eeklo, Eeklo

AZ Jan Palfijn Ghent, Ghent

AZ Sint Lucs Ghent, Ghent

AZ Oudenaarde, Oudenaarde

AZ Vitaz Sint Niklaas - Lokeren, Sint-Niklaas

Netherlands

ZorgSaam ZH DeHonte Terneuzen, Terneuzen, Zeeland